Tumor

Oncology·MeSH: Neoplasms

1014 drugs in development·288 companies·6 clinical trials

Drug Pipeline by Phase

Approved(29)

Drug	Company
abrilada	PFIZER INC (PFE)
afinitor	Novartis AG (NVS)
Alimta®	ELI LILLY & Co (LLY)
amjevita	AMGEN INC (AMGN)
avsola	AMGEN INC (AMGN)
CABOMETYX	EXELIXIS, INC. (EXEL)
carmustine	Amneal Pharmaceuticals, Inc. (AMRX)
Crysvita	Ultragenyx Pharmaceutical Inc. (RARE)
doxorubicin	Amneal Pharmaceuticals, Inc. (AMRX)
emrelis	AbbVie Inc. (ABBV)
everolimus	Mylan II B.V. (MYL)
GilvetMab	Merck & Co., Inc. (MRK)
lorbrena	PFIZER INC (PFE)
lymphoseek kit	Cardinal Health Inc. (CAH)
mekinist	Novartis AG (NVS)
nadofaragene firadenovec	CG Oncology, Inc. (CGON)
Olumiant	ELI LILLY & Co (LLY)
opdivo qvantig	BRISTOL MYERS SQUIBB CO (BMY)
pedmark	FENNEC PHARMACEUTICALS INC. (FENC)
pemetrexed	DR REDDYS LABORATORIES LTD (RDY)
pemfexy	EAGLE PHARMACEUTICALS, INC. (EGRX)
radar	NeoGenomics Inc. (NEO)
romvimza	Deciphera Pharmaceuticals, Inc. (DCPH)
sonalleve	Profound Medical Corp. (PROF)
tevimbra	BeOne Medicines Ltd. (ONC)
triamcinolone acetonide	Teva Pharmaceutical Industries Limited (TEVA)
tykerb	Novartis AG (NVS)
Welireg	Merck & Co., Inc. (MRK)
zoledronic acid	Amneal Pharmaceuticals, Inc. (AMRX)

Phase 3(144)

Drug	Company
177lu-pnt2003	POINT Biopharma Global Inc. (PNT)
177Lu-PSMA-I&T	KYNTRA BIO INC. (KYNB)
5 Azacytidine	Merus N.V. (MRUS)
A10 and AS2-1 Antineoplaston	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
acasunlimab	Genmab A/S (GMAB)
Alectinib	ENANTA PHARMACEUTICALS INC (ENTA)
an2025	Adlai Nortye Ltd. (ANL)
anticancer agents	BeOne Medicines Ltd. (ONC)
Anticancer Agents	BeOne Medicines Ltd. (ONC)
Antineoplastons (A10 & AS2-1)	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Antineoplastons (A10 and AS2-1)	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Antineoplastons A10 and AS2-1	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
avelumab	GH Research PLC (GHRS)
Avelumab	Merck & Co., Inc. (MRK)
Avelumab	Merus N.V. (MRUS)
azd3470	ASTRAZENECA PLC (AZN)
AZD5069	ASTRAZENECA PLC (AZN)
AZD5305	ASTRAZENECA PLC (AZN)
AZD9150	ASTRAZENECA PLC (AZN)
azenosertib	Zentalis Pharmaceuticals, Inc. (ZNTL)
azenosertib (ZN-c3)	Zentalis Pharmaceuticals, Inc. (ZNTL)
bezuclastinib (CGT9486)	Cogent Biosciences, Inc. (COGT)
bgb-15025	BeOne Medicines Ltd. (ONC)
BGB-15025	BeOne Medicines Ltd. (ONC)
BGB-24714	BeOne Medicines Ltd. (ONC)
bgb-43395	BeOne Medicines Ltd. (ONC)
bgb-43395	BeOne Medicines Ltd. (ONC)
BGB-43395	BeOne Medicines Ltd. (ONC)
bgb-b455	BeOne Medicines Ltd. (ONC)
BGB-B455	BeOne Medicines Ltd. (ONC)
BGB-C354	BeOne Medicines Ltd. (ONC)
bhv-1530	Biohaven Ltd. (BHVN)
Cabozantinib	Royalty Pharma plc (RPRX)
Cemiplimab	ENANTA PHARMACEUTICALS INC (ENTA)
cemiplimab+fianlimab fixed dose combination	REGENERON PHARMACEUTICALS, INC. (REGN)
cetuximab	Incyte Corp. (INCY)
Cetuximab	BeOne Medicines Ltd. (ONC)
Cetuximab	BRISTOL MYERS SQUIBB CO (BMY)
cgt9486	Cogent Biosciences, Inc. (COGT)
chemotherapy	Incyte Corp. (INCY)
chemotherapy	BeOne Medicines Ltd. (ONC)
chemotherapy	SPECTRUM PHARMACEUTICALS INC (SPPI)
Chemotherapy	BeOne Medicines Ltd. (ONC)
Chemotherapy	ARS Pharmaceuticals, Inc. (SPRY)
DB-1305/BNT325	BioNTech SE (BNTX)
Divarasib	ENANTA PHARMACEUTICALS INC (ENTA)
elironrasib	REVOLUTION MEDICINES, INC. (RVMD)
eltanexor	Karyopharm Therapeutics Inc. (KPTI)
Entrectinib	ENANTA PHARMACEUTICALS INC (ENTA)
epacadostat	Incyte Corp. (INCY)
ERAS-0015 in combination	Erasca, Inc. (ERAS)
ERAS-4001 in combination	Erasca, Inc. (ERAS)
ersodetug	Rezolute, Inc. (RZLT)
etoposide	Black Diamond Therapeutics, Inc. (BDTX)
Etoposide	BioNTech SE (BNTX)
Etoposide phosphate	Black Diamond Therapeutics, Inc. (BDTX)
fdc fianlimab+cemiplimab	REGENERON PHARMACEUTICALS, INC. (REGN)
FLOT	AGENUS INC (AGEN)
FOLFIRI-HD	IGM Biosciences, Inc. (IGMS)
folfox	Incyte Corp. (INCY)
FOLFOX or FOLFIRI	IGM Biosciences, Inc. (IGMS)
FOLFOX+QL1706+Cetuximab	KYNTRA BIO INC. (KYNB)
Four week alternating FOLFOX and FOLFIRI	IGM Biosciences, Inc. (IGMS)
fruquintinib in combination with sintilimab	HUTCHMED (China) Limited (HCM)
hmpl-453	HUTCHMED (China) Limited (HCM)
hmpl-a251	HUTCHMED (China) Ltd (HMDCF)
hmpl-a580	HUTCHMED (China) Ltd (HMDCF)
hmpl-a580	HUTCHMED (China) Limited (HCM)
hmpl-a83	HUTCHMED (China) Ltd (HMDCF)
horse anti-thymocyte globulin	ENANTA PHARMACEUTICALS INC (ENTA)
HS-20117 combined HS-20093 and 5-FU	IGM Biosciences, Inc. (IGMS)
HS-20117 combined Platinum-containing chemotherapy	IGM Biosciences, Inc. (IGMS)
HS-20117+FOLFIRI	IGM Biosciences, Inc. (IGMS)
HS-20117+mFOLFOX6	IGM Biosciences, Inc. (IGMS)
inca00186	Incyte Corp. (INCY)
inca036873	Incyte Corp. (INCY)
inca33890	Incyte Corp. (INCY)
incb0123667	Incyte Corp. (INCY)
incb081776	Incyte Corp. (INCY)
incb106385	Incyte Corp. (INCY)
incb161734	Incyte Corp. (INCY)
incb177054	Incyte Corp. (INCY)
incb186748	Incyte Corp. (INCY)
incmga00012	Incyte Corp. (INCY)
investigator's choice chemotherapy	Genmab A/S (GMAB)
Ipatasertib	ENANTA PHARMACEUTICALS INC (ENTA)
IV Rilvegostomig	ASTRAZENECA PLC (AZN)
JDQ443	Novartis AG (NVS)
KEYTRUDA®	Merck & Co., Inc. (MRK)
Lartesertib	Merck & Co., Inc. (MRK)
Lazertinib	ENANTA PHARMACEUTICALS INC (ENTA)
lutetium[177lu] oxodotreotide	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
LY3537982	ELI LILLY & Co (LLY)
MEDI4736	ASTRAZENECA PLC (AZN)
mfolfirinox	Incyte Corp. (INCY)
mFOLFIRINOX	Tango Therapeutics, Inc. (TNGX)
MK-0472	Merck & Co., Inc. (MRK)
MK-1084	Merck & Co., Inc. (MRK)
MK-3120	Merck & Co., Inc. (MRK)
MK-4280	Merck & Co., Inc. (MRK)
MK-4280	Merus N.V. (MRUS)
MK-4280A	Merus N.V. (MRUS)
MK-4280A	Merck & Co., Inc. (MRK)
mRNA-4359	Moderna, Inc. (MRNA)
Naporafenib	Erasca, Inc. (ERAS)
New Formulation of Niraparib and Abiraterone Acetate	Myovant Sciences Ltd. (MYOV)
nirogacestat	SpringWorks Therapeutics, Inc. (SWTX)
octreotide lar	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
Other Combination Anti-Cancer Therapies	ENANTA PHARMACEUTICALS INC (ENTA)
Pemetrexed	BRISTOL MYERS SQUIBB CO (BMY)
Pemetrexed	ELI LILLY & Co (LLY)
pertuzumab	ENANTA PHARMACEUTICALS INC (ENTA)
Pertuzumab IV	ENANTA PHARMACEUTICALS INC (ENTA)
pnt2003	POINT Biopharma Global Inc. (PNT)
rabbit anti-thymocyte globulin	ENANTA PHARMACEUTICALS INC (ENTA)
regn15505+cemiplimab	REGENERON PHARMACEUTICALS, INC. (REGN)
retifanlimab	Incyte Corp. (INCY)
rp1 in combination with nivolumab	Replimune Group, Inc. (REPL)
SC Rilvegostomig	ASTRAZENECA PLC (AZN)
SC rilvegostomig + rHu	ASTRAZENECA PLC (AZN)
Selpercatinib	ELI LILLY & Co (LLY)
selumetinib	GH Research PLC (GHRS)
surzebiclimab	BeOne Medicines Ltd. (ONC)
tak-102	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-188	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-188	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-505	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-505	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-981	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-981	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tebentafusp	Immunocore Holdings plc (IMCR)
Tiragolumab	ENANTA PHARMACEUTICALS INC (ENTA)
tislelizumab	BeOne Medicines Ltd. (ONC)
tislelizumab	BeOne Medicines Ltd. (ONC)
Tislelizumab	BeOne Medicines Ltd. (ONC)
tpst-2003	Tempest Therapeutics, Inc. (TPST)
tpst-2206	Tempest Therapeutics, Inc. (TPST)
tpst-3206	Tempest Therapeutics, Inc. (TPST)
Trametinib	Erasca, Inc. (ERAS)
Trametinib	Novartis AG (NVS)
tsr-042	TESARO, Inc. (TSRO)
zl-1218	Zai Lab Ltd (ZLAB)
zl-1310	Zai Lab Ltd (ZLAB)
zoldonrasib	REVOLUTION MEDICINES, INC. (RVMD)

Phase 2(148)

Drug	Company
AB-106	Nuvation Bio Inc. (NUVB)
Abiraterone Acetate	Myovant Sciences Ltd. (MYOV)
ACR-2316	Acrivon Therapeutics, Inc. (ACRV)
ad-rts-hil-12	Alaunos Therapeutics, Inc. (TCRT)
Adagrasib	FATE THERAPEUTICS INC (FATE)
agen2373	AGENUS INC (AGEN)
Aldesleukin	Twist Bioscience Corp (TWST)
alks 4230	Mural Oncology plc (MURA)
Amivantamab	ENANTA PHARMACEUTICALS INC (ENTA)
apl-101	Apollomics Inc. (APLM)
apl-102	Apollomics Inc. (APLM)
azd5305 microtracer	ASTRAZENECA PLC (AZN)
azd6244	ASTRAZENECA PLC (AZN)
bdb001	Eikon Therapeutics Inc. (EIKN)
bdb018	Eikon Therapeutics Inc. (EIKN)
Belvarafenib	ENANTA PHARMACEUTICALS INC (ENTA)
Bendamustine	FATE THERAPEUTICS INC (FATE)
Bezuclastinib	Cogent Biosciences, Inc. (COGT)
BGB-53038	BeOne Medicines Ltd. (ONC)
BMS-986249	CytomX Therapeutics, Inc. (CTMX)
BMS-986288	CytomX Therapeutics, Inc. (CTMX)
BT5528	BICYCLE THERAPEUTICS PLC (BCYC)
BT8009	BICYCLE THERAPEUTICS PLC (BCYC)
Calcium folinate	BRISTOL MYERS SQUIBB CO (BMY)
Camonsertib	ENANTA PHARMACEUTICALS INC (ENTA)
Camonsertib (RP-3500)	Repare Therapeutics Inc. (RPTX)
capmatinib	Novartis AG (NVS)
capmatinib	Novartis AG (NVS)
CAR-T Cell Therapy	BeOne Medicines Ltd. (ONC)
carbon nanoparticle iron	NYMOX PHARMACEUTICAL CORP (NYMXF)
Cediranib	ASTRAZENECA PLC (AZN)
Cediranib	Merus N.V. (MRUS)
Cediranib	ADMA BIOLOGICS, INC. (ADMA)
Celecoxib	AIM ImmunoTech Inc. (AIM)
Cemiplimab	Merus N.V. (MRUS)
Cemiplimab 350 mg IV	Merus N.V. (MRUS)
Cetrelimab	Janux Therapeutics, Inc. (JANX)
CLDN6 RNA-LPX	BioNTech SE (BNTX)
CLDN6 uRNA-LPX/CLDN6 modRNA-LPX	BioNTech SE (BNTX)
clr 131	Cellectar Biosciences, Inc. (CLRB)
crolibulin	IMMUNE PHARMACEUTICALS INC (IMNP)
cyt-0851	Cyteir Therapeutics, Inc. (CYT)
Cytarabine IT	AIM ImmunoTech Inc. (AIM)
Dacarbazine or Temozolomide	PTC THERAPEUTICS, INC. (PTCT)
daraxonrasib	BRISTOL MYERS SQUIBB CO (BMY)
Darolutamide	ENANTA PHARMACEUTICALS INC (ENTA)
Direct Oral Anticoagulant	Structure Therapeutics Inc. (GPCR)
eflapegrastim	SPECTRUM PHARMACEUTICALS INC (SPPI)
Eflapegrastim	ARS Pharmaceuticals, Inc. (SPRY)
eganelisib	INFINITY PHARMACEUTICALS, INC. (INFI)
Enzalutamide	Novartis AG (NVS)
EOS-448	iTeos Therapeutics, Inc. (ITOS)
Etoposide	AIM ImmunoTech Inc. (AIM)
etoposide phosphate	AIM ImmunoTech Inc. (AIM)
evalstotug	BioAtla, Inc. (BCAB)
Evalstotug (BA3071)	BioAtla, Inc. (BCAB)
exosting	Codiak BioSciences, Inc. (CDAK)
Fludarabine	FATE THERAPEUTICS INC (FATE)
Fludarabine	Twist Bioscience Corp (TWST)
FOLFOX	ENANTA PHARMACEUTICALS INC (ENTA)
fpi-2059	Fusion Pharmaceuticals Inc. (FUSN)
fyarro	Whitehawk Therapeutics, Inc. (WHWK)
gen-009	GENOCEA BIOSCIENCES, INC. (GNCA)
Givastomig	BridgeBio Oncology Therapeutics, Inc. (BBOT)
gomekli	SpringWorks Therapeutics, Inc. (SWTX)
hydroxychloroquine	Q BioMed Inc. (QBIO)
ifosfamide	Black Diamond Therapeutics, Inc. (BDTX)
imm-1-104	Immuneering Corp (IMRX)
IMP321	Immutep Limited (IMMP)
imx-110	Immix Biopharma, Inc. (IMMX)
incb057643	Incyte Corp. (INCY)
incb059872	Incyte Corp. (INCY)
incb086550	Incyte Corp. (INCY)
incb099280	Incyte Corp. (INCY)
incb099318	Incyte Corp. (INCY)
Individual Patient TCR-Transduced PBL	Twist Bioscience Corp (TWST)
infigratinib	LianBio (LIANY)
Interleukin-2	Filana Therapeutics Inc. (FLNA)
Interleukin-2	ENANTA PHARMACEUTICALS INC (ENTA)
iph4502	Innate Pharma S.A. (IPHA)
jtx-8064	Jounce Therapeutics, Inc. (JNCE)
kb-0742	Kronos Bio, Inc. (KRON)
LEE011	Novartis AG (NVS)
Lenvatinib	Merus N.V. (MRUS)
Leronlimab	CytoDyn Inc. (CYDY)
leucovorin	Mirati Therapeutics, Inc. (MRTX)
leucovorin	KYNTRA BIO INC. (KYNB)
Leucovorin	FATE THERAPEUTICS INC (FATE)
Leuprolide Acetate	ENANTA PHARMACEUTICALS INC (ENTA)
Leuprolide Acetate	Janux Therapeutics, Inc. (JANX)
Long-acting leronlimab	CytoDyn Inc. (CYDY)
Lurbinectedin	Jazz Pharmaceuticals plc (JAZZ)
Lutetium Lu 177 Dotatate	ENANTA PHARMACEUTICALS INC (ENTA)
Lutetium Lu 177 Dotatate	Royalty Pharma plc (RPRX)
Maximum Tolerated Dose of leronlimab	CytoDyn Inc. (CYDY)
mirdametinib	SpringWorks Therapeutics, Inc. (SWTX)
Mivavotinib (CB-659)	Calithera Biosciences, Inc. (CALA)
mm-121	MERRIMACK PHARMACEUTICALS INC (MACK)
navicixizumab	OncoMed Pharmaceuticals Inc (OMED)
nazartinib	Novartis AG (NVS)
neo100	NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
nuzefatide pevedotin	BICYCLE THERAPEUTICS PLC (BCYC)
Obinutuzumab	CYTOKINETICS INC (CYTK)
oral veledimex - arm 1	Alaunos Therapeutics, Inc. (TCRT)
oral veledimex - arm 2	Alaunos Therapeutics, Inc. (TCRT)
osimertinib	Novartis AG (NVS)
Panitumumab	FATE THERAPEUTICS INC (FATE)
pc14586	PMV Pharmaceuticals, Inc. (PMVP)
Pemetrexed	FATE THERAPEUTICS INC (FATE)
Pemetrexed	Structure Therapeutics Inc. (GPCR)
poziotinib	Assertio Holdings, Inc. (ASRT)
Pralsetinib	ENANTA PHARMACEUTICALS INC (ENTA)
PYX-107	Pyxis Oncology, Inc. (PYXS)
rad101	Radiopharm Theranostics Limited (RADX)
Ramucirumab	ELI LILLY & Co (LLY)
RP-1664	Repare Therapeutics Inc. (RPTX)
RP-3467	Repare Therapeutics Inc. (RPTX)
RP-3500	Repare Therapeutics Inc. (RPTX)
rtx-224	Rubius Therapeutics, Inc. (RUBY)
rtx-240	Rubius Therapeutics, Inc. (RUBY)
Sapanisertib (CB-228, formerly TAK-228)	Calithera Biosciences, Inc. (CALA)
seribantumab	Elevation Oncology, Inc. (ELEV)
Sirolimus	AIM ImmunoTech Inc. (AIM)
snk02	NKGen Biotech, Inc. (NKGN)
solnerstotug	Sensei Biotherapeutics, Inc. (SNSE)
sotigalimab	Apexigen, Inc. (APGN)
SRK-181	Scholar Rock Holding Corp (SRRK)
Temozolomide	ELI LILLY & Co (LLY)
Temozolomide	AIM ImmunoTech Inc. (AIM)
Temozolomide	PTC THERAPEUTICS, INC. (PTCT)
Temozolomide Oral Product	PTC THERAPEUTICS, INC. (PTCT)
temsirolimus	Black Diamond Therapeutics, Inc. (BDTX)
tislelizumab	Novartis AG (NVS)
tislelizumab	Novartis AG (NVS)
trametinib	Novartis AG (NVS)
TransCon IL-2 β/γ	Ascendis Pharma A/S (ASND)
TransCon TLR7/8 Agonist	Ascendis Pharma A/S (ASND)
trc102	Tracon Pharmaceuticals, Inc. (TCON)
Tuvusertib	Merck & Co., Inc. (MRK)
ulixertinib	Q BioMed Inc. (QBIO)
utidelone	BIOSTAR PHARMACEUTICALS, INC. (BSPM)
Vinorelbine	ELI LILLY & Co (LLY)
vir-5818	Vir Biotechnology, Inc. (VIR)
vobramitamab duocarmazine	MACROGENICS INC (MGNX)
Vobramitamab Duocarmazine (vobra duo)	MACROGENICS INC (MGNX)
vobramitamab duocarmazine 2.0 mg	MACROGENICS INC (MGNX)
vobramitamab duocarmazine 2.7 mg	MACROGENICS INC (MGNX)
zelenectide pevedotin (formerly BT8009)	BICYCLE THERAPEUTICS PLC (BCYC)

Phase 1(383)

Drug	Company
[111in]-fpi-2107	ASTRAZENECA PLC (AZN)
[14c] subasumstat	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
[14c] subasumstat	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
[225ac]-fpi-2068	ASTRAZENECA PLC (AZN)
177lu-pnt6555	POINT Biopharma Global Inc. (PNT)
5-FU	BioNTech SE (BNTX)
a small molecular multi-target kinase inhibitor	UNITED THERAPEUTICS Corp (UTHR)
AB308	Arcus Biosciences, Inc. (RCUS)
AB521	EXELIXIS, INC. (EXEL)
ABBV-181	AbbVie Inc. (ABBV)
ABBV-368	AbbVie Inc. (ABBV)
ABBV-711	AbbVie Inc. (ABBV)
Abiraterone	BioNTech SE (BNTX)
abtl-0812	SCICLONE PHARMACEUTICALS INC (SCLN)
acasunlimab	Genmab A/S (GMAB)
adagrasib	Incyte Corp. (INCY)
ADI-270	Adicet Bio, Inc. (ACET)
adxs-her2	OLD AYALA, INC (AYLA)
ADXS-HER2 (ADXS31-164)	Ayala Pharmaceuticals, Inc. (ADXS)
Aldesleukin	ENANTA PHARMACEUTICALS INC (ENTA)
ALG.APV-527	Aptevo Therapeutics Inc. (APVO)
amg 355	AMGEN INC (AMGN)
amg 410	AMGEN INC (AMGN)
amg 436	AMGEN INC (AMGN)
amg 510	AMGEN INC (AMGN)
an0025	Adlai Nortye Ltd. (ANL)
an4005-dose level 0	Adlai Nortye Ltd. (ANL)
an4005-dose level 1	Adlai Nortye Ltd. (ANL)
an4005-dose level 2	Adlai Nortye Ltd. (ANL)
an4005-dose level 3	Adlai Nortye Ltd. (ANL)
an4005-dose level 4	Adlai Nortye Ltd. (ANL)
an4005-food effect	Adlai Nortye Ltd. (ANL)
an8025 is a multifunctional antibody fusion protein	Adlai Nortye Ltd. (ANL)
an9025	Adlai Nortye Ltd. (ANL)
anti-diarrheal agent	BeOne Medicines Ltd. (BEIGF)
anti-diarrheal agent	BeOne Medicines Ltd. (ONC)
Anti-PD-1	Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Anti-PD-1 monoclonal antibody	Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Anti-PD-1 monoclonal antibody	iTeos Therapeutics, Inc. (ITOS)
anti-thymocyte globulin	ENANTA PHARMACEUTICALS INC (ENTA)
Anticancer agent	iTeos Therapeutics, Inc. (ITOS)
anvumetostat	AMGEN INC (AMGN)
Aplitabart	IGM Biosciences, Inc. (IGMS)
APR-1051	Aprea Therapeutics, Inc. (APRE)
arq 751	ARQULE INC (ARQL)
ASP1570	IGM Biosciences, Inc. (IGMS)
atg-101	HCW Biologics Inc. (HCWB)
atrc-101	Atreca, Inc. (BCEL)
ATRN-119	Aprea Therapeutics, Inc. (APRE)
aube00	CASI Pharmaceuticals, Inc (DE) (CASI)
AUTO6NG	Autolus Therapeutics plc (AUTL)
Avelumab	Immutep Limited (IMMP)
axn-2510	Instil Bio, Inc. (TIL)
axn-2510/imm2510	Instil Bio, Inc. (TIL)
axn-27m/imm27m	Instil Bio, Inc. (TIL)
BBI-825	Boundless Bio, Inc. (BOLD)
BBO-10203	ENANTA PHARMACEUTICALS INC (ENTA)
BBO-10203	BridgeBio Pharma, Inc. (BBIO)
BBO-10203	BridgeBio Oncology Therapeutics, Inc. (BBOT)
bg-75098	BeOne Medicines Ltd. (ONC)
BG-75098	BeOne Medicines Ltd. (ONC)
bg-89894	BeOne Medicines Ltd. (ONC)
BG-89894	BeOne Medicines Ltd. (ONC)
bg-c0902	BeOne Medicines Ltd. (ONC)
BG-C0902	BeOne Medicines Ltd. (ONC)
bg-c0979	BeOne Medicines Ltd. (ONC)
BG-C0979	BeOne Medicines Ltd. (ONC)
bg-c137	BeOne Medicines Ltd. (ONC)
BG-C137	BeOne Medicines Ltd. (ONC)
bg-c477	BeOne Medicines Ltd. (ONC)
BG-C477	BeOne Medicines Ltd. (ONC)
BG-C477	Merus N.V. (MRUS)
bg-c9074	BeOne Medicines Ltd. (ONC)
BG-C9074	BeOne Medicines Ltd. (ONC)
bgb-26808	BeOne Medicines Ltd. (BEIGF)
bgb-26808	BeOne Medicines Ltd. (ONC)
BGB-53038	ENANTA PHARMACEUTICALS INC (ENTA)
bgb-58067	BeOne Medicines Ltd. (ONC)
BGB-58067	BeOne Medicines Ltd. (ONC)
BGB-B455	Merus N.V. (MRUS)
bgb-r046	BeOne Medicines Ltd. (ONC)
BGB-R046	BeOne Medicines Ltd. (ONC)
bgm-2121	PRECISION BIOSCIENCES INC (DTIL)
BI 1831169	ENANTA PHARMACEUTICALS INC (ENTA)
bi-1206	CASI Pharmaceuticals, Inc (DE) (CASI)
Birinapant	IGM Biosciences, Inc. (IGMS)
blu-222	Blueprint Medicines Corp (BPMC)
bms-986258	FIVE PRIME THERAPEUTICS, INC. (FPRX)
BNT151	BioNTech SE (BNTX)
BNT152	BioNTech SE (BNTX)
BNT153	BioNTech SE (BNTX)
BNT314	BioNTech SE (BNTX)
BNT317 DL1	BioNTech SE (BNTX)
BNT317 DL2	BioNTech SE (BNTX)
BNT317 DL3	BioNTech SE (BNTX)
BNT317 DL4	BioNTech SE (BNTX)
BNT317 DL5	BioNTech SE (BNTX)
BNT317 DL6	BioNTech SE (BNTX)
BNT317 DL7	BioNTech SE (BNTX)
BNT326	Merus N.V. (MRUS)
BNT411	BioNTech SE (BNTX)
BP1001-A	BIO-PATH HOLDINGS, INC. (BPTH)
brenetafusp	Immunocore Holdings plc (IMCR)
Brenetafusp and chemotherapy	Immunocore Holdings plc (IMCR)
Brenetafusp and kinase inhibitors	Immunocore Holdings plc (IMCR)
Brenetafusp and monoclonal antibodies and chemotherapy	Immunocore Holdings plc (IMCR)
Brenetafusp and tebentafusp	Immunocore Holdings plc (IMCR)
BT1718	BICYCLE THERAPEUTICS PLC (BCYC)
BT7480	BICYCLE THERAPEUTICS PLC (BCYC)
cabozantinib	Kura Oncology, Inc. (KURA)
CAN-3110	Candel Therapeutics, Inc. (CADL)
CB-708 (ATG-037)	Calithera Biosciences, Inc. (CALA)
CBP-1019	KYNTRA BIO INC. (KYNB)
cemiplimab	REGENERON PHARMACEUTICALS, INC. (REGN)
cetuximab	CHINA PHARMA HOLDINGS, INC. (CPHI)
cetuximab	CASI Pharmaceuticals, Inc (DE) (CASI)
cetuximab	C4 Therapeutics, Inc. (CCCC)
CFT1946	C4 Therapeutics, Inc. (CCCC)
chs-114	Coherus Oncology, Inc. (CHRS)
CHS-114	Merus N.V. (MRUS)
CLD-201 (SuperNova™ / SNV1)	Calidi Biotherapeutics Inc. (CLDI)
CLDN6 CAR-T	BioNTech SE (BNTX)
cldn6 urna-lpx	BioNTech SE (BNTX)
cln-418	Q BioMed Inc. (QBIO)
CLN-418	Cullinan Therapeutics, Inc. (CGEM)
CLN-617	Cullinan Therapeutics, Inc. (CGEM)
CLN-619	Cullinan Therapeutics, Inc. (CGEM)
CLR 121225	Cellectar Biosciences, Inc. (CLRB)
cna3103	Neuphoria Therapeutics Inc. (NEUP)
CRB-601	Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CRB-601 monoclonal antibody	Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CRB-701	Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CT-0508	Carisma Therapeutics Inc. (CARM)
CT-0525	Carisma Therapeutics Inc. (CARM)
CT-1119	Carisma Therapeutics Inc. (CARM)
CT-202	Context Therapeutics Inc. (CNTX)
CT-95	Context Therapeutics Inc. (CNTX)
CTX-471	Compass Therapeutics, Inc. (CMPX)
CUE-102	Cue Biopharma, Inc. (CUE)
CX-2051	CytomX Therapeutics, Inc. (CTMX)
CX-801	CytomX Therapeutics, Inc. (CTMX)
CX-904	CytomX Therapeutics, Inc. (CTMX)
darlifarnib	Kura Oncology, Inc. (KURA)
day301	Day One Biopharmaceuticals, Inc. (DAWN)
DB-1311	KYNTRA BIO INC. (KYNB)
dcr-pdl1	Dicerna Pharmaceuticals Inc (DRNA)
dcr-stat3	Dicerna Pharmaceuticals Inc (DRNA)
dcvax-direct	NORTHWEST BIOTHERAPEUTICS INC (NWBO)
dr30206	HCW Biologics Inc. (HCWB)
drug	BeOne Medicines Ltd. (ONC)
Drug	BeOne Medicines Ltd. (ONC)
DS6051b	Nuvation Bio Inc. (NUVB)
Efbalropendekin alfa (XmAb306 / RG6323)	Xencor Inc (XNCR)
elacestrant	BeOne Medicines Ltd. (ONC)
Elacestrant	BeOne Medicines Ltd. (ONC)
elzovantinib	Turning Point Therapeutics, Inc. (TPTX)
Encorafenib	FATE THERAPEUTICS INC (FATE)
Enzalutamide	Nuvation Bio Inc. (NUVB)
Enzalutamide	BioNTech SE (BNTX)
EO-3021	Elevation Oncology, Inc. (ELEV)
EO-3021 (also known as SYSA1801 or CPO102)	Elevation Oncology, Inc. (ELEV)
EOS-215	iTeos Therapeutics, Inc. (ITOS)
EOS006215	iTeos Therapeutics, Inc. (ITOS)
EOS301984	iTeos Therapeutics, Inc. (ITOS)
ERAS-0015	Erasca, Inc. (ERAS)
ERAS-007	Erasca, Inc. (ERAS)
ERAS-12	Erasca, Inc. (ERAS)
ERAS-3490	Erasca, Inc. (ERAS)
ERAS-4	Erasca, Inc. (ERAS)
ERAS-4001	Erasca, Inc. (ERAS)
ERAS-601	Erasca, Inc. (ERAS)
etigilimab	Mereo BioPharma Group plc (MREO)
etigilimab	OncoMed Pharmaceuticals Inc (OMED)
evt801	KAZIA THERAPEUTICS LTD (KZIA)
exs74539	RECURSION PHARMACEUTICALS, INC. (RXRX)
felezonexor	STEMLINE THERAPEUTICS INC (STML)
FID-022	Fulgent Genetics Inc. (FLGT)
folfiri	Incyte Corp. (INCY)
FOLFOX	BridgeBio Pharma, Inc. (BBIO)
FOLFOX	BridgeBio Oncology Therapeutics, Inc. (BBOT)
fpi-1966	Fusion Pharmaceuticals Inc. (FUSN)
fpi-2053	ASTRAZENECA PLC (AZN)
fpt155	FIVE PRIME THERAPEUTICS, INC. (FPRX)
FT825	FATE THERAPEUTICS INC (FATE)
GAd20-209-FSP, RP2D	Merck & Co., Inc. (MRK)
gemnabp	Incyte Corp. (INCY)
gen1042	Genmab A/S (GMAB)
GEN1042	BioNTech SE (BNTX)
GEN1053	BioNTech SE (BNTX)
GEN1055	BioNTech SE (BNTX)
gen1056	GENMAB A/S (GNMSF)
gen1056	Genmab A/S (GMAB)
GEN1056	BioNTech SE (BNTX)
gen1057	Genmab A/S (GMAB)
gen1079	Genmab A/S (GMAB)
gen1106	Genmab A/S (GMAB)
gl-onc1	GENELUX Corp (GNLX)
Granulocyte colony stimulating factor	IGM Biosciences, Inc. (IGMS)
gs-1811	Jounce Therapeutics, Inc. (JNCE)
gs-2121	GILEAD SCIENCES, INC. (GILD)
gs-9911	GILEAD SCIENCES, INC. (GILD)
hbm1020	Q BioMed Inc. (QBIO)
hbm4003	Q BioMed Inc. (QBIO)
hcb301	Turnstone Biologics Corp. (TSBX)
hh-101	China Health Industries Holdings, Inc. (CHHE)
hqp1351	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
hro761	NOVARTIS AG (NVSEF)
hro761	Novartis AG (NVS)
HS-20117 combined HS-20093	IGM Biosciences, Inc. (IGMS)
HS-20117+CAPEOX	IGM Biosciences, Inc. (IGMS)
IDE-161	IDEAYA Biosciences, Inc. (IDYA)
IDE275 (GSK959)	IDEAYA Biosciences, Inc. (IDYA)
IDE397	IDEAYA Biosciences, Inc. (IDYA)
IDE705 (GSK101)	IDEAYA Biosciences, Inc. (IDYA)
im-1340	Immunome Inc. (IMNM)
im-3050	Immunome Inc. (IMNM)
imatinib	Kura Oncology, Inc. (KURA)
IMC-R117C (PIWIL-1)	Immunocore Holdings plc (IMCR)
imgc936	ImmunoGen, Inc. (IMGN)
IMGC936	MACROGENICS INC (MGNX)
Imiquimod Cream	IGM Biosciences, Inc. (IGMS)
IMP321	Merus N.V. (MRUS)
Interleukin-2	Merus N.V. (MRUS)
itraconazole	KYNTRA BIO INC. (KYNB)
Itraconazole	Merus N.V. (MRUS)
jh021	West Pharmaceutical Services Inc. (WST)
JZP898	Jazz Pharmaceuticals plc (JAZZ)
kd033	Sanofi (SNY)
kin-2787	KINNATE BIOPHARMA INC. (KNTE)
kin-3248	KINNATE BIOPHARMA INC. (KNTE)
KSQ-001EX	Filana Therapeutics Inc. (FLNA)
KSQ-001EX	ENANTA PHARMACEUTICALS INC (ENTA)
KSQ-004EX	ENANTA PHARMACEUTICALS INC (ENTA)
KSQ-004EX	Filana Therapeutics Inc. (FLNA)
KSQ-004EX	Merus N.V. (MRUS)
KT-253	Kymera Therapeutics, Inc. (KYMR)
KT-333	Kymera Therapeutics, Inc. (KYMR)
kzr-261	Kezar Life Sciences, Inc. (KZR)
LB101	Centessa Pharmaceuticals plc (CNTA)
leucovorin	CHINA PHARMA HOLDINGS, INC. (CPHI)
Lopinavir and Ritonavir Tablets	BioNTech SE (BNTX)
loxo-292	LOXO ONCOLOGY, INC. (LOXO)
ly3200882	ELI LILLY & Co (LLY)
ly3300054	ELI LILLY & Co (LLY)
LY4050784	ELI LILLY & Co (LLY)
ly4052031	ELI LILLY & Co (LLY)
LY4101174	ELI LILLY & Co (LLY)
M0324	Merck & Co., Inc. (MRK)
M0324	Merus N.V. (MRUS)
M0324	Tango Therapeutics, Inc. (TNGX)
M3554	Merck & Co., Inc. (MRK)
M9466	IGM Biosciences, Inc. (IGMS)
mb-101	Fortress Biotech Inc. (FBIO)
mb-101	Fortress Biotech Inc. (FBIO)
mFOLFIRINOX	Merck & Co., Inc. (MRK)
MGC026	MACROGENICS INC (MGNX)
MGC026 Dose Escalation	MACROGENICS INC (MGNX)
MGC026 Dose for Expansion	MACROGENICS INC (MGNX)
MGC028	MACROGENICS INC (MGNX)
MK-1484	SUTRO BIOPHARMA, INC. (STRO)
mnpr-101-dfo*-89zr	Monopar Therapeutics (MNPR)
mnpr-101-lu	Monopar Therapeutics (MNPR)
mnpr-101-pcta-177lu	Monopar Therapeutics (MNPR)
mnpr-101-zr	Monopar Therapeutics (MNPR)
MRG007	ArriVent BioPharma, Inc. (AVBP)
mrtx0902	Mirati Therapeutics, Inc. (MRTX)
mrtx849	Mirati Therapeutics, Inc. (MRTX)
MT-304	ENANTA PHARMACEUTICALS INC (ENTA)
mt-6402	Molecular Templates, Inc. (MTEM)
MVA-209-FSP, RP2D	Merck & Co., Inc. (MRK)
nab-sirolimus	Mirati Therapeutics, Inc. (MRTX)
nana-val	Viracta Therapeutics, Inc. (VIRX)
narazaciclib	TRAWS PHARMA, INC. (ONTX)
ngm438	NGM BIOPHARMACEUTICALS INC (NGM)
ngm831	NGM BIOPHARMACEUTICALS INC (NGM)
NK Cell Infusion	Filana Therapeutics Inc. (FLNA)
NT-I7	Merck & Co., Inc. (MRK)
NUV-1511	Nuvation Bio Inc. (NUVB)
NUV-868	Nuvation Bio Inc. (NUVB)
NUV-868	KYNTRA BIO INC. (KYNB)
NVL-330	Nuvalent, Inc. (NUVL)
nxp800	Nuvectis Pharma, Inc. (NVCT)
nxp900	Nuvectis Pharma, Inc. (NVCT)
Olaparib	Nuvation Bio Inc. (NUVB)
Olaparib 200-300 mg BID, daily	Repare Therapeutics Inc. (RPTX)
omtx705	GT Biopharma, Inc. (GTBP)
onc206	CHIMERIX INC (CMRX)
oncr-177	Oncorus, Inc. (ONCR)
Onivyde	PTC THERAPEUTICS, INC. (PTCT)
other therapeutic agents	BeOne Medicines Ltd. (ONC)
Other Therapeutic Agents	BeOne Medicines Ltd. (ONC)
panitumumab	AMGEN INC (AMGN)
Paroxetine	Merus N.V. (MRUS)
PD-L1 t-haNK	ImmunityBio, Inc. (IBRX)
Pedmark® STS	Merus N.V. (MRUS)
pelcitoclax	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
Pertuzumab Injection	BioNTech SE (BNTX)
pf-8046052	LAVA Therapeutics NV (LVTX)
pimivalimab	Jounce Therapeutics, Inc. (JNCE)
PLD	IGM Biosciences, Inc. (IGMS)
PLN-101095	PLIANT THERAPEUTICS, INC. (PLRX)
plogosertib (plogo)	Bio Green Med Solution, Inc. (BGMSP)
premedication	Genmab A/S (GMAB)
prn1371	Principia Biopharma Inc. (PRNB)
promitil	Rafael Holdings, Inc. (RFL)
prt3789	Prelude Therapeutics Inc (PRLD)
prt7732	Prelude Therapeutics Inc (PRLD)
pt-112	SCICLONE PHARMACEUTICALS INC (SCLN)
PYX-106	Pyxis Oncology, Inc. (PYXS)
PYX-201	Pyxis Oncology, Inc. (PYXS)
qtx3034	QUANTA INC (QNTA)
qtx3046	QUANTA INC (QNTA)
qtx3544	QUANTA INC (QNTA)
Rabbit Anti thymocyte globulin	ENANTA PHARMACEUTICALS INC (ENTA)
Ramucirumab	IGM Biosciences, Inc. (IGMS)
Recombinant Human Hyaluronidase	ASTRAZENECA PLC (AZN)
rhIL-15	Filana Therapeutics Inc. (FLNA)
Ritonavir	BioNTech SE (BNTX)
rmc-5552	REVOLUTION MEDICINES, INC. (RVMD)
RP-3467 at assigned dose and schedule	Repare Therapeutics Inc. (RPTX)
RP-6306	IGM Biosciences, Inc. (IGMS)
RP3	Replimune Group, Inc. (REPL)
rxdx-105	Ignyta, Inc. (RXDX)
S095035	Tango Therapeutics, Inc. (TNGX)
Sacituzumab govitecan	IDEAYA Biosciences, Inc. (IDYA)
setidegrasib	CHINA PHARMA HOLDINGS, INC. (CPHI)
sibp-a10	CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. (CBPO)
sim0505	NextCure, Inc. (NXTC)
sl-801	STEMLINE THERAPEUTICS INC (STML)
sl-901	STEMLINE THERAPEUTICS INC (STML)
sqz-aac-hpv	SQZ Biotechnologies Co (SQZB)
sqz-pbmc-hpv	SQZ Biotechnologies Co (SQZB)
ST101	Myovant Sciences Ltd. (MYOV)
ST101	Merus N.V. (MRUS)
ST101	PTC THERAPEUTICS, INC. (PTCT)
ST101	Royalty Pharma plc (RPRX)
ST101	Janux Therapeutics, Inc. (JANX)
subasumstat	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
subasumstat	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
sw-682	SpringWorks Therapeutics, Inc. (SWTX)
sy-5609	Syros Pharmaceuticals, Inc. (SYRS)
TAK-188	Merus N.V. (MRUS)
taladegib	Ignyta, Inc. (RXDX)
Talazoparib	Repare Therapeutics Inc. (RPTX)
Talazoparib	PTC THERAPEUTICS, INC. (PTCT)
Tazemetostat	ENANTA PHARMACEUTICALS INC (ENTA)
tbio-6517	Turnstone Biologics Corp. (TSBX)
tbs-2025	TuHURA Biosciences, Inc./NV (HURA)
tcellvax	Regen BioPharma Inc (RGBPP)
tcrt-eso-a2	Athenex, Inc. (ATNX)
Temozolomide	Janux Therapeutics, Inc. (JANX)
Temozolomide	Royalty Pharma plc (RPRX)
Temozolomide	Myovant Sciences Ltd. (MYOV)
tev-56278	Teva Pharmaceutical Industries Limited (TEVA)
Tilsotolimod	AbbVie Inc. (ABBV)
tislelizumab	Q BioMed Inc. (QBIO)
tislelizumab	GT Biopharma, Inc. (GTBP)
tln-372	IGM Biosciences, Inc. (IGMS)
tln-372 in combination with cetuximab	IGM Biosciences, Inc. (IGMS)
toripalimab	Q BioMed Inc. (QBIO)
tpst-1495	Tempest Therapeutics, Inc. (TPST)
tpst-1495 once daily or on intermittent schedule	Tempest Therapeutics, Inc. (TPST)
tpx-0046	Turning Point Therapeutics, Inc. (TPTX)
trametinib	C4 Therapeutics, Inc. (CCCC)
Trifluridine + Tipiracil	IGM Biosciences, Inc. (IGMS)
TRK-950	IGM Biosciences, Inc. (IGMS)
tsr-022	TESARO, Inc. (TSRO)
tsr-033	TESARO, Inc. (TSRO)
Venetoclax	IGM Biosciences, Inc. (IGMS)
vir-5525	Vir Biotechnology, Inc. (VIR)
wtx-124	Werewolf Therapeutics, Inc. (HOWL)
wtx-712	Werewolf Therapeutics, Inc. (HOWL)
XB010	EXELIXIS, INC. (EXEL)
XB371	EXELIXIS, INC. (EXEL)
XB628	EXELIXIS, INC. (EXEL)
XL309	EXELIXIS, INC. (EXEL)
XmAb808	Xencor Inc (XNCR)
xmt-2056	Mersana Therapeutics, Inc. (MRSN)
zanzalintinib	EXELIXIS, INC. (EXEL)
Zimberelimab	Arcus Biosciences, Inc. (RCUS)
zl-6201	Zai Lab Ltd (ZLAB)
Zotiraciclib	Black Diamond Therapeutics, Inc. (BDTX)
zw191	Zymeworks Inc. (ZYME)

Preclinical(114)

Drug	Company
244c8	ENUMERAL BIOMEDICAL HOLDINGS, INC. (ENUM)
388d4	ENUMERAL BIOMEDICAL HOLDINGS, INC. (ENUM)
Aarvik ADC program	ArriVent BioPharma, Inc. (AVBP)
adp-520	Adaptimmune Therapeutics PLC (ADAP)
adp-600	Adaptimmune Therapeutics PLC (ADAP)
aktx-101	Akari Therapeutics Plc (AKTX)
Allogeneic CAR T cell therapy	Intellia Therapeutics, Inc. (NTLA)
allogeneic mait cell therapy	Pluri Inc. (PLUR)
Alpha-201 Macro1	Candel Therapeutics, Inc. (CADL)
Alpha-beta T-cell therapies for cancer	Editas Medicine, Inc. (EDIT)
ALTA-002	ALX ONCOLOGY HOLDINGS INC (ALXO)
Antibody drug conjugate (ADC) candidates	Fulgent Genetics Inc. (FLGT)
apkci inhibitor	WINDTREE THERAPEUTICS INC /DE/ (WINT)
apn-346958	Atreca, Inc. (BCEL)
apn-497444	Atreca, Inc. (BCEL)
apvo451	Aptevo Therapeutics Inc. (APVO)
apvo603	Aptevo Therapeutics Inc. (APVO)
apvo711	Aptevo Therapeutics Inc. (APVO)
ba3142	BioAtla, Inc. (BCAB)
ba3361	BioAtla, Inc. (BCAB)
BP1003	BIO-PATH HOLDINGS, INC. (BPTH)
cab-nectin 4 x cab-cd3	BioAtla, Inc. (BCAB)
CAR-T and Veto Cell combination (CAR-T Veto Cell therapy)	Cell Source, Inc. (CLCS)
CB-668	Calithera Biosciences, Inc. (CALA)
CBO421	Cidara Therapeutics, Inc. (CDTX)
cf33 oncolytic virus therapy	RenovoRx, Inc. (RNXT)
chs-1000	Coherus Oncology, Inc. (CHRS)
ck-103	Checkpoint Therapeutics, Inc. (CKPT)
CLD-400 (RTNova)	Calidi Biotherapeutics Inc. (CLDI)
CPI-182	Corvus Pharmaceuticals, Inc. (CRVS)
CPI-935	Corvus Pharmaceuticals, Inc. (CRVS)
cryptophycin-adc	Lantern Pharma Inc. (LTRN)
diffronc	Regen BioPharma Inc (RGBPP)
dnase-armored car t	Xenetic Biosciences, Inc. (XBIO)
duracar	Regen BioPharma Inc (RGBPP)
enLIGHTEN™ Discovery Platform (platform-level entry)	Candel Therapeutics, Inc. (CADL)
EO-1022	Elevation Oncology, Inc. (ELEV)
fpa157	FIVE PRIME THERAPEUTICS, INC. (FPRX)
fyarro + adagrasib	Whitehawk Therapeutics, Inc. (WHWK)
GPC3-targeted CAR T	CRISPR Therapeutics AG (CRSP)
gsk4381562	Coherus Oncology, Inc. (CHRS)
gtb-5550	GT Biopharma, Inc. (GTBP)
hcw11-018b	HCW Biologics Inc. (HCWB)
HER3-ADC (unnominated)	Elevation Oncology, Inc. (ELEV)
hpn601	Harpoon Therapeutics, Inc. (HARP)
ifabotuzumab	HUMANIGEN, INC (HGEN)
im-1335	Immunome Inc. (IMNM)
inb-300	IN8BIO, INC. (INAB)
inb-600	IN8BIO, INC. (INAB)
io112	IO Biotech, Inc. (IOBT)
io170	IO Biotech, Inc. (IOBT)
iv rhdnase i	Xenetic Biosciences, Inc. (XBIO)
jtx-1484	Jounce Therapeutics, Inc. (JNCE)
jtx-2134	Jounce Therapeutics, Inc. (JNCE)
km10544	Emmaus Life Sciences, Inc. (EMMA)
kros 301	Kairos Pharma, LTD. (KAPA)
kva12123	TuHURA Biosciences, Inc./NV (HURA)
ladr 10	LadRx Corp (LADX)
ladr 7	LadRx Corp (LADX)
ladr 8	LadRx Corp (LADX)
ladr 9	LadRx Corp (LADX)
ladr-10	LadRx Corp (LADX)
ladr-7	LadRx Corp (LADX)
ladr-8	LadRx Corp (LADX)
ladr-9	LadRx Corp (LADX)
ladr10	LadRx Corp (LADX)
ladr7	LadRx Corp (LADX)
ladr8	LadRx Corp (LADX)
ladr9	LadRx Corp (LADX)
linebacker	IMPACT BIOMEDICAL INC. (IBO)
linebacker-1	IMPACT BIOMEDICAL INC. (IBO)
linebacker-2	IMPACT BIOMEDICAL INC. (IBO)
lockbody platform products	Centessa Pharmaceuticals plc (CNTA)
mait cells	Pluri Inc. (PLUR)
mapkapk2 inhibitor	METASTAT, INC. (MTST)
mdvac	Orgenesis Inc. (ORGS)
MGC030	MACROGENICS INC (MGNX)
MIE-101	Mosaic ImmunoEngineering Inc. (CPMV)
mm-111	MERRIMACK PHARMACEUTICALS INC (MACK)
mnpr-101-ac	Monopar Therapeutics (MNPR)
Moderna development candidate - GPC3	Carisma Therapeutics Inc. (CARM)
mstar antibody	OPKO HEALTH, INC. (OPK)
neo-ptc-01	Neon Therapeutics, Inc. (NTGN)
neurohub	BRAIN SCIENTIFIC INC. (BRSF)
nexi-005	NexImmune, Inc. (NEXI)
nkx070	Nkarta, Inc. (NKTX)
onc212	CHIMERIX INC (CMRX)
Pan-mutant BRAF degrader program (proprietary)	Nurix Therapeutics, Inc. (NRIX)
Pan-mutant BRAF program (mutant BRAF degraders)	Nurix Therapeutics, Inc. (NRIX)
Pb212-VMT-⍺-NET	Lantheus Holdings, Inc. (LNTH)
pcs11t	Processa Pharmaceuticals, Inc. (PCSA)
pnt2004	POINT Biopharma Global Inc. (PNT)
pop1 program	Propanc Biopharma, Inc. (PPCB)
rad52 inhibitor	Rain Oncology Inc. (RAIN)
rt-ar001	REBUS HOLDINGS, INC. (NSPX)
rxdx-106	Ignyta, Inc. (RXDX)
rxdx-107	Ignyta, Inc. (RXDX)
SBI-183	AXIM BIOTECHNOLOGIES, INC. (AXIM)
sgr-3515	Schrodinger, Inc. (SDGR)
sl-1001	STEMLINE THERAPEUTICS INC (STML)
SNAP-CAR Platform	Coeptis Therapeutics Holdings Inc. (COEP)
SPX-1009	AXIM BIOTECHNOLOGIES, INC. (AXIM)
t-loop	Orgenesis Inc. (ORGS)
tetra-specific antibody	OPKO HEALTH, INC. (OPK)
theralink pan-tumor assay 2.0	THERALINK TECHNOLOGIES, INC. (THER)
thor-707	Synthorx, Inc. (THOR)
tpst-3003	Tempest Therapeutics, Inc. (TPST)
tpst-4003	Tempest Therapeutics, Inc. (TPST)
trop2 adc	Peak Bio, Inc. (PKBO)
ttx-riga	Transcode Therapeutics, Inc. (RNAZ)
Undisclosed (Solid Tumors)	FATE THERAPEUTICS INC (FATE)
Unnamed enLIGHTEN™ candidate encoding IL-12 and IL-15	Candel Therapeutics, Inc. (CADL)
VPS4A inhibitors (novel series)	Calithera Biosciences, Inc. (CALA)
zw209	Zymeworks Inc. (ZYME)

Unknown(16)

Drug	Company
ADXS-HOT	Ayala Pharmaceuticals, Inc. (ADXS)
Any other SSRI/SNRI not already specified	ENANTA PHARMACEUTICALS INC (ENTA)
Astellas theranostics collaboration	Actinium Pharmaceuticals, Inc. (ATNM)
CB-020	Caribou Biosciences, Inc. (CRBU)
COMET instrument (Lunaphore)	BIO-TECHNE Corp (TECH)
ecDNA directed therapeutic candidates (ecDTx)	Boundless Bio, Inc. (BOLD)
Granulocyte colony-stimulating factor	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
HER-2 targeting ARC (CD47 combination program)	Actinium Pharmaceuticals, Inc. (ATNM)
HER3 targeting ARC	Actinium Pharmaceuticals, Inc. (ATNM)
HLX14	Organon & Co. (OGN)
lutathera	NOVARTIS AG (NVSEF)
lutathera	Novartis AG (NVS)
mn-029	MEDICINOVA INC (MNOV)
not specified	Turnstone Biologics Corp. (TSBX)
Precise Tumor	MYRIAD GENETICS INC (MYGN)
tafinlar/mekinist	Novartis AG (NVS)

BLA Filed(2)

Drug	Company
larotrectinib	LOXO ONCOLOGY, INC. (LOXO)
PNT2003	Lantheus Holdings, Inc. (LNTH)

Early Phase 1(12)

Drug	Company
Filgrastim	AIM ImmunoTech Inc. (AIM)
FOLFIRI	FATE THERAPEUTICS INC (FATE)
FOLFOX	FATE THERAPEUTICS INC (FATE)
hydrocortisone	AIM ImmunoTech Inc. (AIM)
ISOtretinoin	AIM ImmunoTech Inc. (AIM)
Mesna	AIM ImmunoTech Inc. (AIM)
Sotorasib	FATE THERAPEUTICS INC (FATE)
Thiotepa	AIM ImmunoTech Inc. (AIM)
Topotecan IT	AIM ImmunoTech Inc. (AIM)
Trifluridine/tipiracil	FATE THERAPEUTICS INC (FATE)
Tucatinib	FATE THERAPEUTICS INC (FATE)
Vincristine	AIM ImmunoTech Inc. (AIM)

N/A(2)

Drug	Company
LockBody technology platform	Centessa Pharmaceuticals plc (CNTA)
Pb212-VMT-α-NET	Lantheus Holdings, Inc. (LNTH)

Phase 1/Phase 2(138)

Drug	Company
[203pb]vmt-α-net	Perspective Therapeutics, Inc. (CATX)
[212pb]vmt-α-net	Perspective Therapeutics, Inc. (CATX)
177lu-fap-2286	Novartis AG (NVS)
5-fu	Genmab A/S (GMAB)
5-fu	GENMAB A/S (GNMSF)
68ga-fap-2286	Novartis AG (NVS)
a2b395	SAB BIOTHERAPEUTICS, INC. (SABS)
a2b543	SAB BIOTHERAPEUTICS, INC. (SABS)
a2b543	Gene Biotherapeutics, Inc. (CRXM)
a2b694	SAB BIOTHERAPEUTICS, INC. (SABS)
a2b694	Gene Biotherapeutics, Inc. (CRXM)
abiraterone	Incyte Corp. (INCY)
adg126	Sanofi (SNY)
all-trans retinoic acid	Incyte Corp. (INCY)
anti pd-1/l1	AMGEN INC (AMGN)
apg-1387	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
bgb-3245	SpringWorks Therapeutics, Inc. (SWTX)
bhv-1510	Biohaven Ltd. (BHVN)
blu-924	Blueprint Medicines Corp (BPMC)
BNT142	BioNTech SE (BNTX)
BNT3212	BioNTech SE (BNTX)
bnt3214	BioNTech SE (BNTX)
BNT326	BioNTech SE (BNTX)
BNT327	BioNTech SE (BNTX)
bpx-603	BELLICUM PHARMACEUTICALS, INC (BLCM)
brimarafenib	SpringWorks Therapeutics, Inc. (SWTX)
cemiplimab	Biohaven Ltd. (BHVN)
cemiplimab	VERTEX PHARMACEUTICALS INC / MA (VRTX)
cemiplimab	Sensei Biotherapeutics, Inc. (SNSE)
cetuximab	Sanofi (SNY)
cetuximab	AC Immune SA (ACIU)
cetuximab	Mirati Therapeutics, Inc. (MRTX)
cetuximab	REVOLUTION MEDICINES, INC. (RVMD)
cetuximab	Novartis AG (NVS)
CGT4255	Cogent Biosciences, Inc. (COGT)
chemotherapy	Ascendis Pharma A/S (ASND)
chemotherapy	Oric Pharmaceuticals, Inc. (ORIC)
Chemotherapy drug	Ascendis Pharma A/S (ASND)
combination therapy	SpringWorks Therapeutics, Inc. (SWTX)
cpi-0209	CONSTELLATION PHARMACEUTICALS INC (CNST)
cr-001	CRESCENT BIOPHARMA, INC. (CBIO)
cr-002	CRESCENT BIOPHARMA, INC. (CBIO)
cr-003	CRESCENT BIOPHARMA, INC. (CBIO)
dcc-3009	Deciphera Pharmaceuticals, Inc. (DCPH)
dcc-3084	Deciphera Pharmaceuticals, Inc. (DCPH)
dcc-3116	Deciphera Pharmaceuticals, Inc. (DCPH)
decoy20	Indaptus Therapeutics, Inc. (INDP)
Dinutuximab	ELI LILLY & Co (LLY)
envometinib	Immuneering Corp (IMRX)
gen1042	Genmab A/S (GMAB)
gen1053	GENMAB A/S (GNMSF)
gen1053	Genmab A/S (GMAB)
gen1055	Genmab A/S (GMAB)
gen1055	GENMAB A/S (GNMSF)
gen1057	GENMAB A/S (GNMSF)
gen1078	GENMAB A/S (GNMSF)
gen1078	Genmab A/S (GMAB)
gen1079	GENMAB A/S (GNMSF)
gen1106	GENMAB A/S (GNMSF)
gen1286	GENMAB A/S (GNMSF)
gen1286	Genmab A/S (GMAB)
gi-101	Innovation Pharmaceuticals Inc. (IPIX)
gi-101a	Innovation Pharmaceuticals Inc. (IPIX)
gi-108	Innovation Pharmaceuticals Inc. (IPIX)
GM-CSF	ELI LILLY & Co (LLY)
hec169096	SUNSHINE BIOPHARMA INC. (SBFM)
hpn328	Harpoon Therapeutics, Inc. (HARP)
imc-r117c	Immunocore Holdings plc (IMCR)
imm-1-104 + dabrafenib	Immuneering Corp (IMRX)
imm-1-104 + modified folfirinox	Immuneering Corp (IMRX)
imm-1-104 monotherapy	Immuneering Corp (IMRX)
imm-6-415	Immuneering Corp (IMRX)
imp1734	Eikon Therapeutics Inc. (EIKN)
iov-5001	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
iph4502	Innate Pharma SA (IPHYF)
Itraconazole	BioNTech SE (BNTX)
ivonescimab	REVOLUTION MEDICINES, INC. (RVMD)
jab-23e73	X4 Pharmaceuticals, Inc (XFOR)
jdq443	Novartis AG (NVS)
lee011	Novartis AG (NVS)
lenvatinib	Innovation Pharmaceuticals Inc. (IPIX)
lp-184	Lantern Pharma Inc. (LTRN)
m9140	GH Research PLC (GHRS)
mdna11	Medicenna Therapeutics Corp. (MDNAF)
mdx2001	OPKO HEALTH, INC. (OPK)
mdx2003	OPKO HEALTH, INC. (OPK)
mfolfox6	AC Immune SA (ACIU)
miransertib	ARQULE INC (ARQL)
monalizumab	AC Immune SA (ACIU)
mrtx1719	Mirati Therapeutics, Inc. (MRTX)
nc762	NextCure, Inc. (NXTC)
Neladalkib	Nuvalent, Inc. (NUVL)
olaparib	Incyte Corp. (INCY)
oral repotrectinib	TG THERAPEUTICS, INC. (TGTX)
oral repotrectinib	Turning Point Therapeutics, Inc. (TPTX)
oric-114	Oric Pharmaceuticals, Inc. (ORIC)
Paroxetine	BioNTech SE (BNTX)
pemetrexed 500 mg/m2	Inhibrx Biosciences, Inc. (INBX)
phase 1b	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
platinum-based doublet chemotherapy	REGENERON PHARMACEUTICALS, INC. (REGN)
platinum-based doublet chemotherapy	VERTEX PHARMACEUTICALS INC / MA (VRTX)
Pumitamig	BioNTech SE (BNTX)
REC-617	RECURSION PHARMACEUTICALS, INC. (RXRX)
regn7075	VERTEX PHARMACEUTICALS INC / MA (VRTX)
regn7075	REGENERON PHARMACEUTICALS, INC. (REGN)
rezatapopt	PMV Pharmaceuticals, Inc. (PMVP)
rucaparib	Incyte Corp. (INCY)
sar445877	Sanofi (SNY)
sgn1	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
slate	Gritstone bio, Inc. (GRTS)
sns-101	Sensei Biotherapeutics, Inc. (SNSE)
son-1010	SONNET BIOTHERAPEUTICS HOLDINGS, INC. (BURG)
son-1210	SONNET BIOTHERAPEUTICS HOLDINGS, INC. (BURG)
sqz-eapc-hpv	SQZ Biotechnologies Co (SQZB)
standard chemotherapy	Genmab A/S (GMAB)
surufatinib and tislelizumab _ part 1	HUTCHMED (China) Limited (HCM)
surufatinib and tislelizumab _ part 2	HUTCHMED (China) Limited (HCM)
tc-520	TCR2 THERAPEUTICS INC. (TCRR)
THE-630	Theseus Pharmaceuticals, Inc. (THRX)
tislelizumab	Indaptus Therapeutics, Inc. (INDP)
tislelizumab	HUTCHMED (China) Limited (HCM)
TNG462	Tango Therapeutics, Inc. (TNGX)
TNG908	Tango Therapeutics, Inc. (TNGX)
tno155	Novartis AG (NVS)
tno155	Novartis AG (NVS)
toripalimab	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
toripalimab	HUTCHMED (China) Limited (HCM)
trifluridine-tipiracil	VERTEX PHARMACEUTICALS INC / MA (VRTX)
trifluridine-tipiracil	REGENERON PHARMACEUTICALS, INC. (REGN)
ttx-mc138	Transcode Therapeutics, Inc. (RNAZ)
tulmimetostat	Novartis AG (NVS)
Tulmimetostat	Novartis AG (NVS)
vilastobart	Xilio Therapeutics, Inc. (XLO)
VMT-α-NET	Perspective Therapeutics, Inc. (CATX)
wtx-330	Werewolf Therapeutics, Inc. (HOWL)
XmAb662	Xencor Inc (XNCR)
xtx202	Xilio Therapeutics, Inc. (XLO)
xtx301	Xilio Therapeutics, Inc. (XLO)

Phase 2/Phase 3(11)

Drug	Company
Actimab-A	Actinium Pharmaceuticals, Inc. (ATNM)
eik1004	Eikon Therapeutics Inc. (EIKN)
eik1004-001	Eikon Therapeutics Inc. (EIKN)
eik1005	Eikon Therapeutics Inc. (EIKN)
inbrx-106 - hexavalent ox40 agonist antibody	Inhibrx Biosciences, Inc. (INBX)
surufatinib	HUTCHMED (China) Limited (HCM)
surufatinib	HUTCHMED (China) Limited (HCM)
surufatinib	HUTCHMED (China) Ltd (HMDCF)
surufatinib combined with camrelizumab	HUTCHMED (China) Limited (HCM)
tak-103	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
Telisotuzumab Adizutecan	AbbVie Inc. (ABBV)

Phase 4(15)

Drug	Company
5-FU	IGM Biosciences, Inc. (IGMS)
avapritinib	Blueprint Medicines Corp (BPMC)
axitinib	Incyte Corp. (INCY)
BAT8008 for Injection	Merus N.V. (MRUS)
bms-986484	BRISTOL MYERS SQUIBB CO (BMY)
bms-986500	BRISTOL MYERS SQUIBB CO (BMY)
BMS-986504	BRISTOL MYERS SQUIBB CO (BMY)
Darolutamide	Myovant Sciences Ltd. (MYOV)
Enzalutamide	KYNTRA BIO INC. (KYNB)
Leuprolide Acetate	Myovant Sciences Ltd. (MYOV)
mRNA-4157	Moderna, Inc. (MRNA)
nazartinib	NOVARTIS AG (NVSEF)
osimertinib	NOVARTIS AG (NVSEF)
saruparib	ASTRAZENECA PLC (AZN)
toripalimab	Coherus Oncology, Inc. (CHRS)

Compare drugs

abrilada vs afinitor abrilada vs Alimta®abrilada vs amjevita

Frequently asked questions

How many drugs are in development for Tumor?

BioSniper tracks 1014 drugs in development for Tumor across 288 companies.

How many clinical trials target Tumor?

There are 6 clinical trials targeting Tumor tracked by BioSniper.

Deep-dive into Tumor

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis